Literature DB >> 23436819

An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart.

Eva Tritsch1, Youssef Mallat, Florence Lefebvre, Nicolas Diguet, Brigitte Escoubet, Jocelyne Blanc, Leon J De Windt, Daniele Catalucci, Grégoire Vandecasteele, Zhenlin Li, Mathias Mericskay.   

Abstract

AIMS: The expression of the sodium/calcium exchanger NCX1 increases during cardiac hypertrophy and heart failure, playing an important role in Ca(2+) extrusion. This increase is presumed to result from stress signalling induced changes in the interplay between transcriptional and post-transcriptional regulations. We aimed to determine the impact of the SRF transcription factor known to regulate the NCX1 promoter and microRNA genes, on the expression of NCX1 mRNA and protein and annexin A5 (AnxA5), a Ca(2+)-binding protein interacting with NCX1 and increased during HF. METHODS AND
RESULTS: NCX1 mRNA was decreased while the protein was increased in the failing heart of the cardiomyocyte-restricted SRF knock-out mice (SRF(HKO)). The induction of NCX1 mRNA by the pro-hypertrophic drug phenylephrine observed in control mice was abolished in the SRF(HKO) though the protein was strongly increased. AnxA5 protein expression profile paralleled the expression of NCX1 protein in the SRF(HKO). MiR-1, a microRNA regulated by SRF, was decreased in the SRF(HKO) and repressed by phenylephrine. In vitro and in vivo manipulation of miR-1 levels and site-directed mutagenesis showed that NCX1 and AnxA5 mRNAs are targets of miR-1. AnxA5 overexpression slowed down Ca(2+) extrusion during caffeine application in adult rat cardiomyocytes.
CONCLUSION: Our study reveals the existence of a complex regulatory loop where SRF regulates the transcription of NCX1 and miR-1, which in turn functions as a rheostat limiting the translation of NCX1 and AnxA5 proteins. The decrease of miR-1 and increase of AnxA5 appear as important modulators of NCX1 expression and activity during heart failure.

Entities:  

Keywords:  Annexin; Cardiomyopathy; NCX1; SRF; microRNA

Mesh:

Substances:

Year:  2013        PMID: 23436819     DOI: 10.1093/cvr/cvt042

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

1.  MicroRNA-103-1 selectively downregulates brain NCX1 and its inhibition by anti-miRNA ameliorates stroke damage and neurological deficits.

Authors:  Antonio Vinciguerra; Luigi Formisano; Pierpaolo Cerullo; Natascia Guida; Ornella Cuomo; Alba Esposito; Gianfranco Di Renzo; Lucio Annunziato; Giuseppe Pignataro
Journal:  Mol Ther       Date:  2014-06-23       Impact factor: 11.454

Review 2.  MicroRNAs in cardiovascular ageing.

Authors:  Timon Seeger; Reinier A Boon
Journal:  J Physiol       Date:  2015-07-05       Impact factor: 5.182

3.  Micro-RNAs as promising biomarkers in cardiac diseases.

Authors:  Mariama Akodad; Mathias Mericskay; François Roubille
Journal:  Ann Transl Med       Date:  2016-12

4.  Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents.

Authors:  Neil Hoa; Lisheng Ge; Kenneth S Korach; Ellis R Levin
Journal:  Mol Cell Endocrinol       Date:  2017-11-07       Impact factor: 4.102

5.  Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Authors:  K Weber; N Rostert; S Bauersachs; G Wess
Journal:  Mol Cell Biochem       Date:  2015-01-09       Impact factor: 3.396

6.  Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.

Authors:  Nicolas Diguet; Samuel A J Trammell; Cynthia Tannous; Robin Deloux; Jérôme Piquereau; Nathalie Mougenot; Anne Gouge; Mélanie Gressette; Boris Manoury; Jocelyne Blanc; Marie Breton; Jean-François Decaux; Gareth G Lavery; István Baczkó; Joffrey Zoll; Anne Garnier; Zhenlin Li; Charles Brenner; Mathias Mericskay
Journal:  Circulation       Date:  2017-12-07       Impact factor: 29.690

Review 7.  Epigenetic regulation in heart failure.

Authors:  Soo Young Kim; Cyndi R Morales; Thomas G Gillette; Joseph A Hill
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

8.  Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.

Authors:  Tania Zaglia; Paola Ceriotti; Antonio Campo; Giulia Borile; Andrea Armani; Pierluigi Carullo; Valentina Prando; Raffaele Coppini; Vladimiro Vida; Tomas O Stølen; Wisløff Ulrik; Elisabetta Cerbai; Giovanni Stellin; Giuseppe Faggian; Diego De Stefani; Marco Sandri; Rosario Rizzuto; Fabio Di Lisa; Tullio Pozzan; Daniele Catalucci; Marco Mongillo
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

9.  Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis.

Authors:  Aude Angelini; Zhenlin Li; Mathias Mericskay; Jean-François Decaux
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

Review 10.  MicroRNAs Based Therapy of Hypertrophic Cardiomyopathy: The Road Traveled So Far.

Authors:  Catarina Roma-Rodrigues; Luís R Raposo; Alexandra R Fernandes
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.